mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.06 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
0.083 |
0.06 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.07 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |